LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Lowering Monte Rosa Therapeutics, Inc. (GLUE) Q4 25 Estimate To -0.47 From -0.24 3/20/2025 7:39:58 PM
  • Wedbush Is Lowering Monte Rosa Therapeutics, Inc. (GLUE) Q3 25 Estimate To -0.45 From -0.23 3/20/2025 7:39:46 PM
  • Wedbush Is Lowering Monte Rosa Therapeutics, Inc. (GLUE) Q2 25 Estimate To -0.43 From -0.21 3/20/2025 7:39:31 PM
  • Wedbush Is Lowering Monte Rosa Therapeutics, Inc. (GLUE) Q1 25 Estimate To -0.41 From -0.20 3/20/2025 7:39:19 PM
  • Wedbush Reiterates Monte Rosa Therapeutics, Inc. (GLUE) At Outperform With $17 Up From $15 Price Target 3/20/2025 7:38:53 PM
  • Monte Rosa Therapeutics Q4 Net Income $13.44 Mln Vs. Net Loss $33.25 Mln Last Year 3/20/2025 8:00:12 AM
  • Monte Rosa Therapeutics Appoints Eric A. Hughes To Board 12/13/2024 7:04:28 AM
  • Wedbush Is Raising Monte Rosa Therapeutics, Inc. (GLUE) FY24 Rev. Estimate To 34.4 M From 29.6 M 11/7/2024 11:06:46 PM
  • Wedbush Is Raising Monte Rosa Therapeutics, Inc. (GLUE) FY25 Estimate To -0.88 From -0.91 11/7/2024 11:06:27 PM
  • Wedbush Is Raising Monte Rosa Therapeutics, Inc. (GLUE) FY24 Estimate To -1.43 From -1.63 11/7/2024 11:06:18 PM
  • Wedbush Reiterates Monte Rosa Therapeutics, Inc. (GLUE) At Outperform With $15 Price Target 11/7/2024 11:05:51 PM
  • Monte Rosa Therapeutics Enters License Agreement With Novartis To Advance VAV1 MGDs 10/28/2024 7:19:41 AM
  • Wedbush Reiterates Monte Rosa Therapeutics, Inc. (GLUE) At Outperform With $11 Price Target 8/19/2024 9:19:03 PM
  • Wedbush Is Raising Monte Rosa Therapeutics, Inc. (GLUE) FY24 Rev. Estimate To 14.6 M From 14.4 M 8/8/2024 5:22:53 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap